FDA — authorised 16 October 2007
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: approved
🇺🇸 Ixempra Kit in United States
FDA authorised Ixempra Kit on 16 October 2007
Marketing authorisations
FDA — authorised 16 October 2007
- Application: NDA022065
- Marketing authorisation holder: R-PHARM US LLC
- Local brand name: IXEMPRA KIT
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
Ixempra Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Ixempra Kit approved in United States?
Yes. FDA authorised it on 16 October 2007; FDA authorised it on 16 October 2007.
Who is the marketing authorisation holder for Ixempra Kit in United States?
BRISTOL MYERS SQUIBB holds the US marketing authorisation.